Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |